Kovina Therapeutics

Business Services · Indiana, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1210 Waterway Blvd Ste 2000, Indianapoli...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Kovina Therapeutics

Kovina Therapeutics is a preclinical stage biotechnology company focused on developing targeted antiviral therapeutics aimed at eliminating HPV-driven cancers and preventing the progression of premalignant infections caused by Human Papillomavirus (HPV). The company is creating first-in-class small molecule antivirals that specifically target the HPV E6 oncogene, triggering apoptosis in infected cells while sparing healthy tissue. Kovina is committed to providing novel treatment options for patients with HPV, offering hope for non-surgical alternatives to treat existing cancers and infections. Their innovative approach addresses a significant unmet need in HPV care, as current treatments often come with substantial side effects.Explore more
Kovina Therapeutics's Social MediaPopular SearchesKovina Therapeutics IncKovina TherapeuticsSIC Code 87,873NAICS Code 54,541Show more

Is Kovina Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Kovina Therapeutics

Compare insights from companies similar to Kovina Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Kovina Therapeutics

<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
-
KB
Kyle BrewerCo-Founder
<$5M
11-50
Private
$81.2M
2008
RG
Rafal GoraczniakDirector, Platform Development
<$5M
11-50
Private
-
2019
Seema Nandi, Founder & Chief Executive Officer at SelSym Biotech
Seema NandiFounder & CEO
<$5M
11-50
Private
$65M
2018
<$5M
1-10
Private
-
-
LS
Linda SuInterim Chief Financial Officer
<$5M
1-10
Private
<$5M
2018
RF
Robert ForgeyPresident and CEO Iaso Therapeutics
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Kovina Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Kovina Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kovina Therapeutics.

Kovina Therapeutics Tech Stack

A closer look at the technologies used by Kovina Therapeutics

Top Business Services Companies

Frequently Asked Questions Regarding Kovina Therapeutics

What is Kovina Therapeutics's official website?
Kovina Therapeutics's official website is www.kovina.com
What is Kovina Therapeutics's Revenue?
Kovina Therapeutics's revenue is <$5 Million
What is Kovina Therapeutics's SIC code?
Kovina Therapeutics's SIC: 87,873
What is Kovina Therapeutics's NAICS code?
Kovina Therapeutics's NAICS: 54,541
How many employees does Kovina Therapeutics have?
Kovina Therapeutics has 1-10 employees
What industry does Kovina Therapeutics belong to?
Kovina Therapeutics is in the industry of: Business Services, Research & Development
What is Kovina Therapeutics competition?
Kovina Therapeutics top competitors include: Ceptur Therapeutics, SelSym Biotech, Inomagen Therapeutics, Iaso Therapeutics
What technology does Kovina Therapeutics use?
Some of the popular technologies that Kovina Therapeutics uses are: Adobe Typekit, Google Tag Manager, Google Global Site Tag, Webflow
What does Kovina Therapeutics do?

Kovina Therapeutics is a preclinical stage biotechnology company focused on developing targeted antiviral therapeutics aimed at eliminating HPV-driven cancers and preventing the progression of premalignant infections caused by Human Papillomavirus (HPV). The company is creating first-in-class small molecule antivirals that specifically target the H... PV E6 oncogene, triggering apoptosis in infected cells while sparing healthy tissue. Kovina is committed to providing novel treatment options for patients with HPV, offering hope for non-surgical alternatives to treat existing cancers and infections. Their innovative approach addresses a significant unmet need in HPV care, as current treatments often come with substantial side effects.Read More

What are Kovina Therapeutics social media links?
Kovina Therapeutics Linkedin page
Is Kovina Therapeutics a public company?
Kovina Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Kovina Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.